CG Life Combines With The Considered+AI
July 28, 2026
CG Life, a specialized pharma commercialization agency for rare and hard-to-treat diseases, has combined with The Considered+AI, an AI-native pharma agency built for generative-AI-era commercialization. The combination is intended to create a new commercialization partner model blending CG Life’s rare disease/precision medicine expertise with The Considered’s AI-native approach and proprietary behavior-change framework.
- Buyers
- CG Life, The Considered+AI
- Targets
- The Considered+AI, CG Life
- Industry
- Healthcare Services
- Location
- Illinois, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
insitro to Acquire CombinAbleAI
January 12, 2026
AI & Machine Learning
insitro announced it will acquire CombinAbleAI and launch its TherML (Therapeutic Machine Learning) platform to unify AI-driven therapeutic design across drug modalities. The acquisition is expected to close in late January 2026, with CombinAbleAI’s team continuing to operate in Israel as a new insitro R&D center focused on large-molecule design.
-
LyfeSci Research & Innovation Acquires Clinically Media
January 12, 2026
Healthcare Services
LyfeSci Research & Innovation, a Chicago-area full-service CRO, has acquired Clinically Media to bring patient recruitment capabilities in-house and expand end-to-end clinical trial execution. Clinically Media — a data-driven patient recruitment agency focused on dermatology, neurology, and psychiatry — will be integrated into LyfeSci's CRO services and operate under the LyfeSci brand to improve protocol feasibility, site selection, and enrollment optimization.
-
TandemAI Merges with Perpetual Medicines to Expand Peptide and AI Drug Discovery Capabilities
July 10, 2025
Biotechnology
TandemAI and Perpetual Medicines have merged, with the combined company operating under the TandemAI name. Perpetual Medicines will operate as a separate entity within TandemAI to extend the firm's capabilities into computational peptide design and integrated synthesis, while leadership from both companies will continue in senior roles; financial terms were not disclosed.
-
CG Life Acquires Berry & Company Public Relations
May 21, 2024
Marketing & Advertising
CG Life has acquired Berry & Company Public Relations, a New York City–based public relations agency specializing in life sciences and medical technology. The deal brings Berry's leadership team and roughly 12 staff into CG Life to expand its PR, social media, and crisis communications capabilities and strengthen its New York presence for biopharma and medical device clients.
-
CG Life Acquires Toolhouse
March 22, 2024
Marketing & Advertising
CG Life, a Chicago-based integrated life-sciences agency, has acquired Toolhouse, a Bellingham, Washington digital agency that supports biopharma and life sciences with marketing technology, data-driven insights, and user-centric design. The acquisition (closed March 22) expands CG Life's omnichannel and technology-enabled capabilities; financial terms were not disclosed.
-
CG Life Acquires Philadelphia-Based McDAY
April 1, 2020
Marketing & Advertising
CG Life, a life-science-focused integrated marketing and communications agency, has acquired McDAY, a strategic marketing communications firm based in Center City, Philadelphia. The acquisition expands CG Life’s strategic communications capabilities in the pharmaceutical, biotech and fine chemicals markets; financial terms were not disclosed.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.